Glyciphage-VG 1mg/500mg/0.2mg Tablet SR
Marketer
Franco-Indian Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyciphage-VG 1mg/500mg/0.2mg Tablet SR
Metformin/voglibose/pioglitazone extended-release tablets (1mg/500mg/0.2mg) are categorized as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Consistent meals and readily available glucose sources (sugary foods or juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Uses of Glyciphage-VG 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyciphage-VG 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyciphage-VG 1mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
Common Side effects of Glyciphage-VG 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyciphage-VG 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyciphage-VG 1mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
How Glyciphage-VG 1mg/500mg/0.2mg Tablet SR works:
Metformin/Voglibose/Pioglitazone extended-release tablets (1mg/500mg/0.2mg) combine three agents to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Glyciphage-VG 1mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glyciphage-VG 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glyciphage-VG 1mg/500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Glyciphage-VG 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Glyciphage-VG 1mg/500mg/0.2mg Tablet SR is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Glyciphage-VG 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in severe cases.
What if you forget to take Glyciphage-VG 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glyciphage-VG 1mg/500mg/0.2mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glyciphage-VG 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently